CMF-01137 | ZNF292 | down-regulates | RUNX3 | activates | R-194 | 11 | 3 | Drugs (8) |
CMF-01138 | ZNF292 | down-regulates | RUNX3 | activates | R-192 | 11 | 3 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-01991 | PCDH9 | down-regulates | RUNX3 | activates | R-197 | 11 | 5 | Drugs (4) |
CMF-01992 | PCDH9 | down-regulates | RUNX3 | activates | R-192 | 11 | 5 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-02697 | UBE3C | down-regulates | RUNX3 | activates | R-197 | 11 | 1 | Drugs (4) |
CMF-02838 | MST1 | up-regulates | RUNX3 | activates | R-201 | 11 | 1 | Drugs (1) |
CMF-04646 | CYP4F12 | down-regulates | RUNX3 | activates | R-196 | 11 | 2 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
CMF-06056 | OTOA | down-regulates | RUNX3 | activates | R-196 | 11 | 2 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
CMF-08131 | PLEKHG4B | down-regulates | RUNX3 | activates | R-196 | 11 | 2 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
CMF-09768 | MTF1 | down-regulates | RUNX3 | activates | R-196 | 11 | 1 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
CMF-09972 | FBN1 | down-regulates | RUNX3 | activates | R-192 | 11 | 1 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-10864 | PKD1L2 | down-regulates | RUNX3 | activates | R-196 | 11 | 2 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
CMF-11032 | BMP5 | down-regulates | RUNX3 | activates | R-196 | 11 | 3 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
CMF-11147 | MYO18A | down-regulates | RUNX3 | activates | R-196 | 11 | 2 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
CMF-11148 | MYO18A | down-regulates | RUNX3 | activates | R-192 | 11 | 2 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-13859 | ADAMTS8 | down-regulates | RUNX3 | activates | R-192 | 11 | 2 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-16760 | CPNE8 | up-regulates | RUNX3 | activates | R-192 | 11 | 2 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-18053 | PRPF40B | down-regulates | RUNX3 | activates | R-194 | 11 | 6 | Drugs (8) |
CMF-18054 | PRPF40B | down-regulates | RUNX3 | activates | R-192 | 11 | 6 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-19541 | NF1 | up-regulates | RUNX3 | activates | R-196 | 11 | 10 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
CMF-19546 | NF1 | up-regulates | RUNX3 | activates | R-201 | 11 | 10 | Drugs (1) |
CMF-19547 | NF1 | up-regulates | RUNX3 | activates | R-194 | 11 | 10 | Drugs (8) |
CMF-19548 | NF1 | up-regulates | RUNX3 | activates | R-197 | 11 | 10 | Drugs (4) |
CMF-19549 | NF1 | up-regulates | RUNX3 | activates | R-192 | 11 | 10 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-20738 | ALPK1 | up-regulates | RUNX3 | activates | R-194 | 11 | 1 | Drugs (8) |
CMF-22175 | PDGFRA | down-regulates | RUNX3 | activates | R-197 | 11 | 2 | Drugs (4) |
CMF-22176 | PDGFRA | down-regulates | RUNX3 | activates | R-192 | 11 | 2 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-28669 | PCNX | down-regulates | RUNX3 | activates | R-194 | 11 | 5 | Drugs (8) |
CMF-28670 | PCNX | down-regulates | RUNX3 | activates | R-197 | 11 | 5 | Drugs (4) |
CMF-29129 | FOLH1B | down-regulates | RUNX3 | activates | R-196 | 11 | 1 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
CMF-30137 | PRKDC | up-regulates | RUNX3 | activates | R-201 | 11 | 1 | Drugs (1) |
CMF-30664 | SALL4 | down-regulates | RUNX3 | activates | R-196 | 11 | 3 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
CMF-30666 | SALL4 | down-regulates | RUNX3 | activates | R-192 | 11 | 3 | Drugs (56) Regulator Drugs (0)Regulon Drugs (56)LY-2787106, SARGRAMOSTIM, ATN-161, AME-133V, DASATINIB, ABATACEPT, L19IL2, AS-1409, CCR5MAB004, VRC-01LS, VICRIVIROC, VOBARILIZUMAB, CAROTUXIMAB, L19TNFA, APLAVIROC, MARAVIROC, EFALIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, LERONLIMAB, ILORASERTIB, JNJ-26483327, L19SIP 131I, HGS-1025, PF-04605412, SARILUMAB, CENICRIVIROC, APLAVIROC HYDROCHLORIDE, BELATACEPT, XL-228, SATRALIZUMAB, SELGANTOLIMOD, TOLIMIDONE, MAVRILIMUMAB, MOTOLIMOD, TREGALIZUMAB, ERITORAN TETRASODIUM, TOMIVOSERTIB, BMS-813160, PF-04634817, TG100-801, INCB-9471, VICRIVIROC MALEATE, LIFITEGRAST, PF-232798, ZANOLIMUMAB, TELRATOLIMOD, AZD5672, IBALIZUMAB, OCRIPLASMIN, UB-421, ERITORAN, VOLOCIXIMAB, LEVILIMAB, ENMD-981693 |
CMF-30712 | ABCA13 | down-regulates | RUNX3 | activates | R-197 | 11 | 2 | Drugs (4) |